11-hydroxyandrostenedione has been researched along with Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmina, E; Chang, L; Lobo, RA; Miles, RA; Stanczyk, FZ | 1 |
1 other study(ies) available for 11-hydroxyandrostenedione and Hyperplasia
| Article | Year |
|---|---|
The ratio of androstenedione:11 beta-hydroxyandrostenedione is an important marker of adrenal androgen excess in women.
Topics: Adolescent; Adrenal Gland Diseases; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adult; Androgens; Androstenedione; Biomarkers; Dexamethasone; Female; Humans; Hyperplasia; Prospective Studies; Radioimmunoassay | 1992 |